Dataset Information


Characterization of Ath29, a major mouse atherosclerosis susceptibility locus, and identification of Rcn2 as a novel regulator of cytokine expression.

ABSTRACT: Ath29 is an atherosclerosis susceptibility locus on chromosome 9 identified in an intercross between C57BL/6 (B6) and C3H/HeJ (C3H) apolipoprotein E-deficient (apoE(-/-)) mice. This locus was subsequently replicated in two separate intercrosses that developed early or advanced atherosclerotic lesions. The objective of this study was to characterize Ath29 through construction and analysis of a congenic strain and identify underlying candidate genes. A congenic line was constructed by introgressing the chromosomal segment harboring Ath29 from C3H.apoE(-/-) into B6.apoE(-/-) mice. Congenic mice developed significantly smaller early and advance atherosclerotic lesions than B6.apoE(-/-) mice. Microarray analysis revealed 317 genes to be differentially expressed in the aorta of congenic mice compared with B6.apoE(-/-) mice. Pathway analysis of these genes suggested the Ca(2+) signaling pathway to be implicated in regulating atherosclerosis susceptibility. Rcn2 is located underneath the linkage peak of Ath29 and involved in Ca(2+) signaling. Multiple single-nucleotide polymorphisms between B6 and C3H mice were detected within and surrounding Rcn2 with one single-nucleotide polymorphism falling within an upstream cAMP response element. Immunostaining demonstrated its expression in atherosclerotic lesions. Knockdown of Rcn2 with small interfering RNAs resulted in significant reductions in both baseline and oxidized phospholipid-induced VCAM-1 and monocyte chemoattractant protein-1 expression by endothelial cells. Ath29 is confirmed to be a major atherosclerosis susceptibility locus affecting both early and advanced lesion formation in mice, and Rcn2 is identified as a novel regulator of cytokine expression.

SUBMITTER: Manichaikul A 

PROVIDER: S-EPMC3191074 | BioStudies | 2011-01-01


REPOSITORIES: biostudies

Similar Datasets

2010-01-01 | S-EPMC2958254 | BioStudies
2019-01-01 | S-EPMC6819243 | BioStudies
2012-01-01 | S-EPMC3327142 | BioStudies
2015-01-01 | S-EPMC4409543 | BioStudies
2009-01-01 | S-EPMC2738862 | BioStudies
2019-01-01 | S-EPMC6599485 | BioStudies
2017-01-01 | S-EPMC5374004 | BioStudies
2009-01-01 | S-EPMC2685336 | BioStudies
1000-01-01 | S-EPMC2141823 | BioStudies
2008-01-01 | S-EPMC2464279 | BioStudies